Tag: PEP
20
OctoberRaltegravir for Post-Exposure Prophylaxis: Is It a Viable Option?
Raltegravir is still used for HIV post-exposure prophylaxis, but dolutegravir is now preferred due to simpler dosing and better adherence. Learn when raltegravir remains the right choice.
Recent posts
-
6 Jan 2026
Mail-Order Generics: Benefits and Hidden Risks of Home-Delivered Medications
-
11 Dec 2025
Risk Perception: How Patients Assess Generic Drug Safety
-
17 Dec 2025
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
-
29 Oct 2025
How Tolvaptan Affects Blood Pressure in Kidney Disease Patients
-
15 Oct 2025
Albuterol and Cystic Fibrosis: Does It Boost Lung Function?